Investigational Injectable Drug Demonstrates Efficacy in Localized Fat Reduction
Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.
Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.
As GLP-1s grow in popularity, more Americans are rethinking weight loss in the new year.